OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2021
(3)
2024
(2)
2023
(1)
2022
(1)
2017
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
Not available
S-EPMC5625674
|
biostudies-literature
Cite
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020.
Not available
S-EPMC7985673
|
biostudies-literature
Cite
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Not available
S-EPMC8393812
|
biostudies-literature
Cite
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Not available
S-EPMC10905886
|
biostudies-literature
Cite
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
Not available
S-EPMC9352579
|
biostudies-literature
Cite
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Not available
S-EPMC10115649
|
biostudies-literature
Cite
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
Not available
S-EPMC10364875
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets